Latest Headlines

  1. Personalizing The Complete Blood Count Test Could Improve Patient Care 12/11/2024

    Using personalized rather than standard reference points for the routine blood test known as a complete blood count (CBC) could improve assessments of patient health and diagnosis of diseases in earlier stages while patients still appear healthy, according to a study led by Harvard Medical School researchers at Massachusetts General Hospital.

  2. Noul And Limbach Gruppe, Germany's Top Lab Chain, To Sign An Agreement For The Supply Of Milab™ BCM 12/11/2024

    Noul Co., Ltd. (CEO: David Lim, hereunder as "Noul") has signed an agreement with Limbach Group SE, the largest lab chain in Germany to signal for miLab platform's launching in the EU.

  3. Inspira™ Expands HYLA™ Blood Sensor Technology Into Personalized Blood Lab Testing For Rapid Detection Of Serious Medical Conditions 12/10/2024

    Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN, IINNW), ("Inspira Technologies" or the "Company"), a groundbreaking life support technology company, revealed the expansion of its HYLA blood sensor technology ("HYLA") into an immediate personalized Blood Lab Test, aimed at performing real-time patient blood work for the rapid detection in minutes of the potential development of an underlying life-threatening medical condition.

  4. Akoya Biosciences And Neracare Enter Into An Exclusive Global License Agreement For The Development And Commercialization Of The Immunoprint Test For Early-Stage Melanoma Patient Treatment Decisions 12/10/2024

    Akoya Biosciences, Inc,The Spatial Biology Company, and NeraCare, a leading developer of laboratory tests for the prognosis of melanoma, today announced an exclusive global license agreement to develop and commercialize NeraCare’s Immunoprint test on Akoya's multiplexed immunofluorescent platform.

  5. Microbix Assisting EMQN With Novel Genetic-Test EQA Program 12/10/2024

    Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix), a life sciences innovator, manufacturer, and exporter, and EMQN CIC (EMQN), a global supplier of laboratory external quality assessment (“EQA”) schemes for human genomic testing, announce the go-live of a program to support the accurate identification of patients who carry a gene-variant associated with increased susceptibility to hearing loss following treatment with a widely-used class of antibiotics.

  6. Sapio Sciences: Accelerating Innovation In Research And Diagnostics With Science-Aware AI 12/10/2024

    Sapio Sciences, the science-aware lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025.

  7. Transcat Acquires Martin Calibration Inc.'S 7 Labs, Expanding Midwest Service Presence, Including Minneapolis 12/10/2024

    Transcat, Inc. (“Transcat” or the “Company”), a leading provider of accredited calibration services, cost control and optimization services, and distribution and rental of value-added professional grade handheld test, measurement, and control instrumentation, announced that it has acquired privately-held Martin Calibration Inc.

  8. FDA Grants Breakthrough Device Designation To Memed Severity Test For Patients With Suspected Sepsis 12/10/2024

    MeMed, a leader in the emerging field of advanced host response technologies, today announced that the FDA has granted Breakthrough Device Designation (BDD) to its innovative MeMed Severity test.

  9. SolidScience Unveils Compact And Affordable Peptide Synthesizer To Support Research Needs 12/9/2024

    Solid Science Plc, a young and innovative Hungarian biotechnology firm, is excited to introduce the RevoPSy instrument—a compact peptide synthesizer designed to help researchers achieve efficient and reliable peptide synthesis.

  10. Copan Diagnostics Announces FDA Clearance For Innovative Urine Collection Device 12/6/2024

    Copan Diagnostics, a leader in microbiology laboratory innovations, is proud to announce that UriSponge® a urine collection and transport device which uses a new formulation of advanced preservatives to ensure specimen stability for culture, has received clearance from the U.S.